Anika Therapeutics Inc. (ANIK): Price and Financial Metrics
GET POWR RATINGS... FREE!
ANIK POWR Grades
- Value is the dimension where ANIK ranks best; there it ranks ahead of 73.31% of US stocks.
- The strongest trend for ANIK is in Stability, which has been heading up over the past 31 weeks.
- ANIK ranks lowest in Momentum; there it ranks in the 15th percentile.
ANIK Stock Summary
- Price to trailing twelve month operating cash flow for ANIK is currently 64.14, higher than 92.88% of US stocks with positive operating cash flow.
- With a year-over-year growth in debt of -71.23%, Anika Therapeutics Inc's debt growth rate surpasses just 4.47% of about US stocks.
- Over the past twelve months, ANIK has reported earnings growth of -324.47%, putting it ahead of just 6.42% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Anika Therapeutics Inc, a group of peers worth examining would be RDCM, WHG, PMD, KIQ, and NURO.
- ANIK's SEC filings can be seen here. And to visit Anika Therapeutics Inc's official web site, go to www.anikatherapeutics.com.
ANIK Price Target
For more insight on analysts targets of ANIK, see our ANIK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $51.50 | Average Broker Recommendation | 1 (Strong Buy) |
ANIK Stock Price Chart Interactive Chart >
ANIK Price/Volume Stats
| Current price | $39.99 | 52-week high | $48.37 |
| Prev. close | $41.06 | 52-week low | $32.04 |
| Day low | $39.65 | Volume | 335,000 |
| Day high | $41.15 | Avg. volume | 131,241 |
| 50-day MA | $42.63 | Dividend yield | N/A |
| 200-day MA | $38.95 | Market Cap | 575.50M |
Anika Therapeutics Inc. (ANIK) Company Bio
Anika Therapeutics develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. The company was founded in 1983 and is based in Bedford, Massachusetts.
ANIK Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $39.99 | $1.04 | -98% |
Below please find a table outlining a discounted cash flow forecast for ANIK, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Anika Therapeutics Inc ranked in the 5th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 98%. As for the metrics that stood out in our discounted cash flow analysis of Anika Therapeutics Inc, consider:
- In the past 5.76 years, Anika Therapeutics Inc has a compound free cash flow growth rate of -0.21%; that's higher than only 7.81% of free cash flow generating stocks in the Healthcare sector.
- Anika Therapeutics Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -114.17. This coverage rate is greater than that of only 1.44% of stocks we're observing for the purpose of forecasting via discounted cash flows.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -98% |
| 1% | -98% |
| 2% | -98% |
| 3% | -98% |
| 4% | -98% |
| 5% | -98% |
Want more companies with a valuation profile/forecast similar to that of Anika Therapeutics Inc? See ALC, MYOV, VERU, ATRS, and LNTH.
Latest ANIK News From Around the Web
Below are the latest news stories about Anika Therapeutics Inc that investors may wish to consider to help them evaluate ANIK as an investment opportunity.
Introducing Anika Therapeutics (NASDAQ:ANIK), A Stock That Climbed 26% In The Last YearOn average, over time, stock markets tend to rise higher. This makes investing attractive. But if you choose that path... |
Anika Therapeutics (ANIK) Presents At UBS Global Healthcare Virtual Conference - SlideshowThe following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event.... |
Anika Therapeutics (ANIK) Presents At Canaccord Genuity Musculoskeletal Conference - SlideshowThe following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event.... |
Anika to Host its 2021 Virtual Investor Day on June 3, 2021BEDFORD, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to host its 2021 Virtual Investor Day on Thursday, June 3, 2021 beginning at 9:00am EDT. Cheryl Blanchard, President and Chief Executive Officer, and Mike Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will present alongside other members of Anika's executive management team, providing an in-depth overview of its business strategy, product portfolio, R&D pipeline and financial objectives. The event will include presentations followed by a Q&A panel session with senior leadership. A webcast will be available on June 3 and will be available for replay at Investor Rel... |
Anika to Participate in Upcoming Virtual Investor ConferencesBEDFORD, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following three virtual investor conferences in May: The 16th Annual Canaccord Genuity Musculoskeletal Conference on Thursday, May 20, 2021 will host a live presentation starting at 9:00 a.m. ET.The UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 will host a live presentation starting at 8:00 a.m. ET.Oppenheimer’s MedTech, Tools & Diagnostics Summit will post a pre-recorded presentation on Wednesday, May 26, 2021. Webca... |
ANIK Price Returns
| 1-mo | -6.78% |
| 3-mo | 9.71% |
| 6-mo | -6.61% |
| 1-year | 16.49% |
| 3-year | 39.00% |
| 5-year | -19.68% |
| YTD | -11.64% |
| 2020 | -12.71% |
| 2019 | 54.27% |
| 2018 | -37.66% |
| 2017 | 10.11% |
| 2016 | 28.30% |
Continue Researching ANIK
Here are a few links from around the web to help you further your research on Anika Therapeutics Inc's stock as an investment opportunity:Anika Therapeutics Inc (ANIK) Stock Price | Nasdaq
Anika Therapeutics Inc (ANIK) Stock Quote, History and News - Yahoo Finance
Anika Therapeutics Inc (ANIK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...